Successful acquisition of a 2.2 million euro grant for the Core Facility for Medical Proteomics.
A joint effort led by Professor Marius Ueffing, Director of the Institute for Ophthalmic Research in Tübingen, and Dr. Karsten Boldt, Head of the Core Facility for Medical Proteomics—with key partners including the Department of Pathology and Neuropathology led by Professor Stephan Singer, the Department of Neurology and Neurodegenerative Diseases led by Professor Thomas Gasser, PD Dr. Johannes Gloeckner from the DZNE, the Anaesthesiology and Intensive Care Department led by Professor Peter Rosenberger, and the Experimental Pharmacology unit led by Professor Robert Lukowski—has secured a €2.2 million grant from the German Research Foundation (DFG). This funding has enabled the acquisition of two state-of-the-art mass spectrometers, significantly enhancing LC-MS-based capabilities for advanced tissue proteomics and medical research. Furthermore, through strategic collaboration with the Department of Pathology and Neuropathology, the Core Facility is integrating proteomics into medical research to pioneer innovative approaches and transformative discoveries. With an impressive track record of publications in journals such as Nature and PNAS, the facility continues to drive breakthroughs in understanding disease mechanisms and advancing personalized medicine research through collaborative scientific partnerships
